(Q43142497)

14 November 2017

title

Serum uric acid levels and renal damage in hyperuricemic hypertensive patients treated with renin-angiotensin system blockers (English)

1 reference

14 November 2017

Andrea Berni

1

1 reference

14 November 2017

Maria Boddi

2

1 reference

14 November 2017

Elisa Bissoni Fattori

3

1 reference

14 November 2017

Ilaria Cecioni

4

1 reference

14 November 2017

Sabino Berardino

5

1 reference

14 November 2017

Francesca Montuschi

6

1 reference

14 November 2017

Marco Chiostri

7

1 reference

14 November 2017

Loredana Poggesi

8

1 reference

14 November 2017

publication date

4 March 2010

1 reference

Journal of Clinical Hypertension

14 November 2017

published in

1 reference

14 November 2017

volume

23

1 reference

14 November 2017

issue

6

1 reference

14 November 2017

page(s)

675-680

1 reference

Hyperuricemia, low urine urate excretion and target organ damage in arterial hypertension

14 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.33

7 January 2021

Elevated uric acid increases the risk for kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.33

7 January 2021

Uric acid and incident kidney disease in the community

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.33

7 January 2021

Mild hyperuricemia and subclinical renal damage in untreated primary hypertension

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.33

7 January 2021

The controversial role of serum uric acid in essential hypertension: relationships with indices of target organ damage.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.33

7 January 2021

Time to abandon microalbuminuria?

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.33

7 January 2021

Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.33

7 January 2021

Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.33

7 January 2021

Hyperuricemia induces endothelial dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.33

7 January 2021

Combined treatment with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: a review of the current evidence.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.33

7 January 2021

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.33

7 January 2021

The effect of mild hyperuricemia on urinary transforming growth factor beta and the progression of chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.33

7 January 2021

HCV infection facilitates asymptomatic carotid atherosclerosis: preliminary report of HCV RNA localization in human carotid plaques.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.33

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.33

7 January 2021

Uric acid and cardiovascular risk

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.33

7 January 2021

Increased renal resistive index in patients with essential hypertension: a marker of target organ damage.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.33

7 January 2021

Review. The resistive index in renal Doppler sonography: where do we stand?

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.33

7 January 2021

Intrarenal hemodynamic abnormalities in diabetic nephropathy measured by duplex Doppler sonography.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.33

7 January 2021

Renal resistive index early detects chronic tubulointerstitial nephropathy in normo- and hypertensive patients

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.33

7 January 2021

Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.33

7 January 2021

Effect of allopurinol on mortality and hospitalisations in chronic heart failure: a retrospective cohort study

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.33

7 January 2021

Uric acid predicts clinical outcomes in heart failure: insights regarding the role of xanthine oxidase and uric acid in disease pathophysiology

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.33

7 January 2021

Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.33

7 January 2021

Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.33

7 January 2021

Uric acid and the state of the intrarenal renin-angiotensin system in humans

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.33

7 January 2021

Subtle acquired renal injury as a mechanism of salt-sensitive hypertension

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.33

7 January 2021

Identifiers

DOI

10.1038/AJH.2010.33

1 reference

14 November 2017

1 reference